It is well understood that corals harbor diverse microbial communities. Recently, many coral-associated bacteria have been characterized as sources of marine natural products, especially as the coral surface is more nutrient rich than seawater or even sediments. 1,2 Colonization of coral surfaces by bacteria and other microorganisms is mostly nondestructive to corals. Owing to the close spatial vicinity of these biofilm-forming bacteria, it can be expected that the indigenous microbial population is adapted to competitive conditions. 3 The production of secondary metabolites is a common adaptation of these bacteria to compete in such microenvironments. There have been few reports documented on exploration of coralassociated bacteria in the South China Sea as a source of secondary metabolites.
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In order to obtain biologically active natural products from coral-associated bacteria, we studied the marine bacterium Bacillus amyloliquefaciens SCSIO 00856 isolated from the South China Sea gorgonian Junceella juncea. In the preliminary experiments, we found that the culture broth of the strain had strong antibacterial activity towards three bacteria (Escherichia coli, Bacillus subtilis, and Staphyloccocus aureus) and antilarval activity towards laboratory-reared bryozoan Bugula neritina larvae. In this study, a new 24-membered ring lactone, macrolactin V (1) (Figure 1 ), together with four known compounds, macrolactin S (2), 4 4-butoxyphenol (3), 5 4-propoxyphenol (4), 6 and 4-ethoxyphenol (5), 6 was isolated from a culture broth of the strain. Macrolactins are polyene macrolides containing a 24-membered lactone ring. About 20 macrolactins have been chemically characterized, including macrolactins A-U, 7-O-succinyl macrolactin A, and 7-O-succinyl macrolactin F, from marine Bacillus sp. sediment isolate, and 7-O-malonyl macrolactin A from Bacillus subtilis soil isolate. 4, [7] [8] [9] [10] [11] [12] [13] Some of these compounds showed strong antibacterial, anti-tumor, and antivirus activities. 4, 7, [9] [10] [11] [12] [13] The antibacterial activity of 1-5 against four bacterial strains and the antilarval activity of 3-5 against larval settlement of Bugula neritina and Balanus amphitrite larvae were evaluated. This paper deals with the isolation, structural elucidation of 1 and biological activity of 1-5.
The producing strain, Bacillus amyloliquefaciens SCSIO 00856, was isolated from the gorgonian coral Junceella juncea in Sanya, Hainan province, China. The strain culture (2 ml) was used to inoculate 50 ml seed medium consisting of 0.4% yeast extract, 0.4% glucose, 0.5% malt meal, and 1.8% sea salt (pH 7.3), in a 250-ml flask. A volume of 20 ml of the resulting culture was used to inoculate 400 ml of the seed medium, in a 1-l flask. The culture was incubated at 27 1C on a rotary shaker operating at 150 r.p.m. for 5 days. The resulting 400-ml culture was used to inoculate 120 l of production medium, in a 200-l fermenter, containing the following components per liter of water: yeast extract 4 g, malt meal 5 g, glucose 4 g, and sea salt 18 g. The production fermentation tanks were operated at 27 1C, a back-pressure of 0.1 MPa, and an agitation rate of 150 r.p.m. pH was controlled at 7.3 by addition of NaOH. The fermenter was operated for 10 days, at which time the culture was harvested for isolation of metabolites. The culture broth (120 l) was extracted with EtOAc. The EtOAc extract was concentrated in vacuo to afford 13.9 g of residue, which was subjected to column chromatography (CC) on silica gel, using CHCl 3 -MeOH (from 10:0 to 0:10) as eluent. Elution of CC with 8% MeOH in CHCl 3 gave a fraction of 835 mg. The fraction was subsequently subjected to CC on silica gel, eluted with CHCl 3 -MeOH, then purified with semi-preparative HPLC (Luna C18(2), 250Â10 mm i.d., 5 ml min À1 ), using MeOH-water (65:35) as eluent to yield 1 (2.6 mg) and 2 (19.7 mg). Elution of the first CC with 20% MeOH in CHCl 3 gave a 342-mg fraction, which was rechromatographed on a silica gel column using a gradient elution of CHCl 3 -MeOH to yield 3 (60 mg). The fraction (163 mg) eluted with 35% MeOH in CHCl 3 at the first CC was repeatedly subjected to silica gel column using a gradient elution of CHCl 3 -MeOH to yield 4 (7.5 mg) and 5 (7.0 mg). The structures of 3-5 were established by analyzing their 1D NMR spectral data and by comparison with the literature. 5, 6 Compound 1 had the molecular formula of C 24 H 34 O 6 as deduced from NMR spectra and HR-ESI-MS. 13 ) were obviously observed in the NMR spectra of 1, which should be caused by the change of the three-dimensional effect at C-7 position, and suggested that the configuration of ÀOH at C-7 in 1 should be a-configuration instead of b-configuration as it existed in 2 and other previously isolated macrolactins. 4, [7] [8] [9] [10] [11] [12] [13] The suggestion was supported by the NOESY (Figure 3) , in which NOE correlations of H-6b with H-8/H-4 and H-7 with H-8 were observed, whereas no NOE correlations between H-7 and H-9/H-5 were observed, which were in agreement with the MM2 optimized conformation of 1. However, NOE correlations of H-7 with H-9/H-5 were obviously observed in the NOESY of 2. 4 Thus, the structure of 1 was determined as shown and named macrolactin V. The optical rotation value of 1 is À0.08 (c 0.11, MeOH), which is different from that of 2 (À0.62 (c 0.15, MeOH)). 4 The antibacterial activity of compounds 1-5 was measured against E. coli, Bacillus thuringiensis, Bacillus subtilis, and S. aureus using standard disc diffusion assay. 14 The MICs of compound 1-5 were determined by a dilution method. 15 The results showed that macrolactin V (1) had strong antibacterial activity against E. coli, Bacillus subtilis, and S. aureus, with an MIC value of 0.1 mg ml À1 , and no activity against Bacillus thuringiensis, and macrolactin S (2) showed strong antibacterial activity against E. coli and S. aureus with MIC values of 0.3 and 0.1 mg ml À1 , respectively, but weak activity against Bacillus subtilis (MIC 100 mg ml À1 ), which indicated that the configuration of OH-7 could affect the antibacterial activity of the epimers 1 and 2. Compounds 3-5 showed no or weak inhibition towards all tested bacteria.
The antilarval activity of compounds 3-5 was evaluated in settlement inhibition assays with laboratory-reared Bugula neritina (Bryozoa) and Balanus amphitrite (Cirripedia) larvae. The procedures were the same as previously reported. 16 Larval settlement bioassays revealed that 3-5 showed potent antilarval activity towards Bacillus amphitrite larvae with EC 50 values of 23.0, 22.9, and 24.1 mg ml À1 , respectively. However, only 3 could inhibit Bacillus neritina larvae settlement at the concentration of 50 mg ml À1 , but no activity at 25 mg ml À1 , and 4 and 5 were inactive even at 50 mg ml À1 . The EC 50 values of 3-5 against Bacillus amphitrite larvae settlement were lower than the standard requirement of an EC 50 of 25 mg ml À1 established by the US Navy program as an efficacy level for natural antifoulants, indicating that 3-5 are potential selective natural antifouling agents. This was the first time to report 3-5 from culture broths of bacteria and their antilarval activities against marine invertebrate larvae.
EXPERIMENTAL PROCEDURE Taxonomy
Blast search results at EzTaxon.org Server showed that the 16S rRNA gene sequence of the strain SCSIO 00856 has the highest similarity (99.21%) with Bacillus amyloliquefaciens ATCC 23350 T . On the basis of the morphological features and the 16S rRNA gene sequence, the strain SCSIO 00856 was identified as Bacillus amyloliquefaciens and named Bacillus amyloliquefaciens SCSIO 00856. It was deposited at the Guangdong Key Laboratory of Marine Materia Medica, South China Sea Institute of Oceanology, The Chinese Academy of Sciences, China (Accession No. SCSIO 00856). 
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